These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19289348)

  • 1. Development and testing of performance measures for pharmacy services.
    Pillittere-Dugan D; Nau DP; McDonough K; Pierre Z
    J Am Pharm Assoc (2003); 2009; 49(2):212-9. PubMed ID: 19289348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality.
    Academy of Managed Care Pharmacy ; American Pharmacists Association
    J Am Pharm Assoc (2003); 2014; 54(3):228-40. PubMed ID: 24770440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy performance while providing continuous medication monitoring.
    Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
    J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
    J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons Learned from Using Global Outcome Measures to Assess Community Pharmacy Performance.
    Urick BY; Ferreri SP; Shasky C; Pfeiffenberger T; Trygstad T; Farley JF
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1278-1283. PubMed ID: 30479196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
    Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
    J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System.
    Desai V; Nau D; Conklin M; Heaton PC
    J Manag Care Spec Pharm; 2016 Jul; 22(7):779-86. PubMed ID: 27348278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy Quality Alliance: Five phase I demonstration projects: descriptions and lessons learned.
    Doucette WR; Conklin M; Mott DA; Newland B; Plake KS; Nau DP
    J Am Pharm Assoc (2003); 2011; 51(4):544-50. PubMed ID: 21752779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
    Trapskin K; Johnson C; Cory P; Sorum S; Decker C
    J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Store and prescription characteristics associated with primary medication nonadherence.
    Jackson TH; Bentley JP; McCaffrey DJ; Pace P; Holmes E; West-Strum D
    J Manag Care Spec Pharm; 2014 Aug; 20(8):824-32. PubMed ID: 25062076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of costs of community and mail service pharmacy.
    Carroll NV; Brusilovsky I; York B; Oscar R
    J Am Pharm Assoc (2003); 2005; 45(3):336-43. PubMed ID: 15991755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community and ambulatory pharmacy: evaluation of patient care services and billing patterns before implementation of Medicare part D.
    Beatty SJ; Rodis JL; Bellebaum KL; Mehta BH
    J Am Pharm Assoc (2003); 2006; 46(6):707-14. PubMed ID: 17176686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Medication Adherence Among Pharmacies Participating in a North Carolina Enhanced Services Network.
    Urick BY; Bhosle M; Farley JF
    J Manag Care Spec Pharm; 2020 Jun; 26(6):718-722. PubMed ID: 32463769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of medication synchronization on quality care criteria in an independent community pharmacy.
    Hinson JL; Garofoli GK; Elswick BM
    J Am Pharm Assoc (2003); 2017; 57(2):236-240. PubMed ID: 28089522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical care in community pharmacies: practice and research in Denmark.
    Herborg H; Sørensen EW; Frøkjaer B
    Ann Pharmacother; 2007 Apr; 41(4):681-9. PubMed ID: 17389660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction: Medicare quality improvement organizations--activities and partnerships.
    Schulke DG; Krantzberg E; Grant J
    J Manag Care Pharm; 2007 Jul; 13(6 Suppl B):S3-6. PubMed ID: 17672819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.